Global Market Report

Global Age-Related Macular Degeneration (Amd) Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Nov 11, 2018
  • PAGES：147
  • REPORT CODE：GMM124419
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Age-Related Macular Degeneration (Amd) witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Age-Related Macular Degeneration (Amd) market is offered. The research provides insights for the global Age-Related Macular Degeneration (Amd) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Age-Related Macular Degeneration (Amd) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Age-Related Macular Degeneration (Amd) Market Segmentations:

    By Players:

    • Acucela

    • F. Hoffmann-La Roche Ltd

    • Stemcells Inc.

    • Alimera Sciences, Inc.

    • Ophthotech Corporation

    • Bayer Ag.

    • Novartis Ag

    • Regeneron Pharmaceutical, Inc.

    • Glaxosmithkline Plc

    • Neurotech Pharmaceuticals, Inc.


    By Types:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Age-Related Macular Degeneration (Amd) Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Age-Related Macular Degeneration (Amd) Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Age-Related Macular Degeneration (Amd) Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Age-Related Macular Degeneration (Amd) Market Share by Types

      • 1.3.2 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 1 from 2013 to 2025

      • 1.3.3 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 2 from 2013 to 2025

      • 1.3.4 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 3 from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Age-Related Macular Degeneration (Amd) Market Share by End-Users

      • 1.4.2 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 1 from 2013 to 2025

      • 1.4.3 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 2 from 2013 to 2025

      • 1.4.4 Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 3 from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumAge-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Age-Related Macular Degeneration (Amd) Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Age-Related Macular Degeneration (Amd) by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of Age-Related Macular Degeneration (Amd) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Age-Related Macular Degeneration (Amd) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Age-Related Macular Degeneration (Amd) for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Age-Related Macular Degeneration (Amd) for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Age-Related Macular Degeneration (Amd) for End-Users 3


    5 Market Analysis by Major Regions

    • 5.1 Global Age-Related Macular Degeneration (Amd) Production Analysis by Major Regions

    • 5.2 Global Age-Related Macular Degeneration (Amd) Consumption Analysis by Major Regions

    • 5.3 Global Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis


    6 Product Commodity of Age-Related Macular Degeneration (Amd) Market in Major Countries

    • 6.1 Top 5 Export Countries in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Age-Related Macular Degeneration (Amd) Landscape Analysis

    • 7.1 North America Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Types

    • 7.2 North America Age-Related Macular Degeneration (Amd) Landscape Analysis by Major End-Users

    • 7.3 North America Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Countries

      • 7.3.1 United States Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 7.3.2 Canada Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 7.3.3 Mexico Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate


    8 Europe Age-Related Macular Degeneration (Amd) Landscape Analysis

    • 8.1 Europe Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Types

    • 8.2 Europe Age-Related Macular Degeneration (Amd) Landscape Analysis by Major End-Users

    • 8.3 Europe Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Countries

      • 8.3.1 Germany Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.2 UK Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.3 France Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.4 Italy Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.6 Spain Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.7 Belgium Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.8 Poland Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.9 Russia Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 8.3.10 Turkey Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate


    9 Asia Pacific Age-Related Macular Degeneration (Amd) Landscape Analysis

    • 9.1 Asia Pacific Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Types

    • 9.2 Asia Pacific Age-Related Macular Degeneration (Amd) Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Countries

      • 9.3.1 China Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 9.3.2 Japan Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 9.3.4 India Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 9.3.6 South Korea Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 10.3.2 Brazil Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 10.3.3 Nigeria Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

      • 10.3.4 South Africa Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate 

      • 10.3.5 Argentina Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Acucela

      • 11.1.1 Acucela Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 F. Hoffmann-La Roche Ltd

      • 11.2.1 F. Hoffmann-La Roche Ltd Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Stemcells Inc.

      • 11.3.1 Stemcells Inc. Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Alimera Sciences, Inc.

      • 11.4.1 Alimera Sciences, Inc. Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Ophthotech Corporation

      • 11.5.1 Ophthotech Corporation Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Bayer Ag.

      • 11.6.1 Bayer Ag. Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Novartis Ag

      • 11.7.1 Novartis Ag Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Regeneron Pharmaceutical, Inc.

      • 11.8.1 Regeneron Pharmaceutical, Inc. Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Glaxosmithkline Plc

      • 11.9.1 Glaxosmithkline Plc Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Neurotech Pharmaceuticals, Inc.

      • 11.10.1 Neurotech Pharmaceuticals, Inc. Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 86 Figures and 164 Tables)

    • Figure Product Picture

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 1 from 2013 to 2025

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 2 from 2013 to 2025

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Type 3 from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 1 from 2013 to 2025

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 2 from 2013 to 2025

    • Figure Global Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of End-User 3 from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Age-Related Macular Degeneration (Amd) Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Age-Related Macular Degeneration (Amd) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Age-Related Macular Degeneration (Amd)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Age-Related Macular Degeneration (Amd) by Different Types from 2013 to 2025

    • Table Consumption Share of Age-Related Macular Degeneration (Amd) by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Age-Related Macular Degeneration (Amd) by Different End-Users from 2013 to 2025

    • Table Consumption Share of Age-Related Macular Degeneration (Amd) by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global Age-Related Macular Degeneration (Amd) Production by Major Regions

    • Table Global Age-Related Macular Degeneration (Amd) Production Share by Major Regions

    • Figure Global Age-Related Macular Degeneration (Amd) Production Share by Major Regions in 2013

    • Figure Global Age-Related Macular Degeneration (Amd) Production Share by Major Regions in 2018

    • Figure Global Age-Related Macular Degeneration (Amd) Production Share by Major Regions in 2025

    • Table Global Age-Related Macular Degeneration (Amd) Consumption by Major Regions

    • Table Global Age-Related Macular Degeneration (Amd) Consumption Share by Major Regions

    • Figure Global Age-Related Macular Degeneration (Amd) Consumption Share by Major Regions in 2013

    • Figure Global Age-Related Macular Degeneration (Amd) Consumption Share by Major Regions in 2018

    • Figure Global Age-Related Macular Degeneration (Amd) Consumption Share by Major Regions in 2025

    • Table North America Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

    • Table Europe Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Age-Related Macular Degeneration (Amd) market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Age-Related Macular Degeneration (Amd) Consumption by Types from 2013 to 2025

    • Table North America Age-Related Macular Degeneration (Amd) Consumption Share by Types from 2013 to 2025

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2013

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2018

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2025

    • Table North America Age-Related Macular Degeneration (Amd) Consumption by End-Users from 2013 to 2025

    • Table North America Age-Related Macular Degeneration (Amd) Consumption Share by End-Users from 2013 to 2025

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2013

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2018

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2025

    • Table North America Age-Related Macular Degeneration (Amd) Consumption by Major Countries from 2013 to 2025

    • Table North America Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2013

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2018

    • Figure North America Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2025

    • Figure United States Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption by Types from 2013 to 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption Share by Types from 2013 to 2025

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2013

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2018

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption by End-Users from 2013 to 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2013

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2018

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption by Major Countries from 2013 to 2025

    • Table Europe Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2013

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2018

    • Figure Europe Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2025

    • Figure Germany Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure France Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption by Types from 2013 to 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2013

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2018

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2013

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2018

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2025

    • Figure China Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandAge-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure India Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Age-Related Macular Degeneration (Amd) Consumption Share by Major Countries in 2025

    • Figure GCC Countries Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Age-Related Macular Degeneration (Amd) Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Acucela

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acucela

    • Figure Sales and Growth Rate Analysis of Acucela

    • Figure Revenue and Market Share Analysis of Acucela

    • Table Product and Service Introduction of Acucela

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Stemcells Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stemcells Inc.

    • Figure Sales and Growth Rate Analysis of Stemcells Inc.

    • Figure Revenue and Market Share Analysis of Stemcells Inc.

    • Table Product and Service Introduction of Stemcells Inc.

    • Table Company Profile and Development Status of Alimera Sciences, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alimera Sciences, Inc.

    • Figure Sales and Growth Rate Analysis of Alimera Sciences, Inc.

    • Figure Revenue and Market Share Analysis of Alimera Sciences, Inc.

    • Table Product and Service Introduction of Alimera Sciences, Inc.

    • Table Company Profile and Development Status of Ophthotech Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ophthotech Corporation

    • Figure Sales and Growth Rate Analysis of Ophthotech Corporation

    • Figure Revenue and Market Share Analysis of Ophthotech Corporation

    • Table Product and Service Introduction of Ophthotech Corporation

    • Table Company Profile and Development Status of Bayer Ag.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Ag.

    • Figure Sales and Growth Rate Analysis of Bayer Ag.

    • Figure Revenue and Market Share Analysis of Bayer Ag.

    • Table Product and Service Introduction of Bayer Ag.

    • Table Company Profile and Development Status of Novartis Ag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Ag

    • Figure Sales and Growth Rate Analysis of Novartis Ag

    • Figure Revenue and Market Share Analysis of Novartis Ag

    • Table Product and Service Introduction of Novartis Ag

    • Table Company Profile and Development Status of Regeneron Pharmaceutical, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceutical, Inc.

    • Figure Sales and Growth Rate Analysis of Regeneron Pharmaceutical, Inc.

    • Figure Revenue and Market Share Analysis of Regeneron Pharmaceutical, Inc.

    • Table Product and Service Introduction of Regeneron Pharmaceutical, Inc.

    • Table Company Profile and Development Status of Glaxosmithkline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline Plc

    • Figure Sales and Growth Rate Analysis of Glaxosmithkline Plc

    • Figure Revenue and Market Share Analysis of Glaxosmithkline Plc

    • Table Product and Service Introduction of Glaxosmithkline Plc

    • Table Company Profile and Development Status of Neurotech Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurotech Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Neurotech Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Neurotech Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Neurotech Pharmaceuticals, Inc.


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US